Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective

Metastatic prostate cancer is the most common malignant cancer and the second leading cause of death due to various types of cancer among men after lung cancer. This study aimed to analyze the cost-effectiveness of triptorelin, goserelin, and leuprolide in the treatment of the patients with metastat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health regional issues 2024-07, Vol.42, p.100982, Article 100982
Hauptverfasser:	Rezaee, Mehdi, Karimzadeh, Iman, Hashemi-Meshkini, Amir, Zeighami, Shahryar, Bazyar, Mohammad, Lotfi, Farhad, Keshavarz, Khosro
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents, Hormonal - economics Antineoplastic Agents, Hormonal - therapeutic use Cost-Effectiveness Analysis goserelin Goserelin - administration & dosage Goserelin - economics Goserelin - therapeutic use Humans Iran leuprolide Leuprolide - administration & dosage Leuprolide - economics Leuprolide - therapeutic use Male Markov Chains Middle Aged Neoplasm Metastasis prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - economics Quality of Life Quality-Adjusted Life Years triptorelin Triptorelin Pamoate - administration & dosage Triptorelin Pamoate - economics Triptorelin Pamoate - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!